These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 28387960

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P, Czarnecka D, Wolfshaut-Wolak R, Łysek R, Łukaszewska A, Bogacki P, Grodecki J, Mirek-Bryniarska E, Nessler J, Podolec P, Kawecka-Jaszcz K, Pająk A.
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [Abstract] [Full Text] [Related]

  • 23. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Barón AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K.
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
    [Abstract] [Full Text] [Related]

  • 24. Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia.
    Livori AC, Ademi Z, Ilomäki J, Nelson AJ, Bell JS, Morton JI.
    Heart Lung Circ; 2024 Oct; 33(10):1439-1449. PubMed ID: 38964944
    [Abstract] [Full Text] [Related]

  • 25. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ, Robinson JG, Annis IE, Hickson RP, Bell JS, Hartikainen J, Fang G.
    J Am Coll Cardiol; 2017 Sep 26; 70(13):1543-1554. PubMed ID: 28935030
    [Abstract] [Full Text] [Related]

  • 26. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
    Amann U, Kirchberger I, Heier M, Thilo C, Kuch B, Meisinger C.
    Eur J Intern Med; 2018 Jan 26; 47():62-68. PubMed ID: 28826823
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.
    Meurice T, Tricot O, Lemesle G, Deneve M, Lejeune P, Biausque F, Cordier C, Savoye C, Hennebert O, Taghipour K, Sivery B, Pruvost P, Alaoui M, Carpentier L, Segrestin B, Lamblin N, Bauters C.
    Arch Cardiovasc Dis; 2015 Jan 26; 108(6-7):340-6. PubMed ID: 25858539
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
    Kocas C, Abaci O, Oktay V, Coskun U, Bostan C, Yildiz A, Arat Ozkan A, Gurmen T, Ersanli M.
    J Clin Pharm Ther; 2013 Dec 26; 38(6):476-9. PubMed ID: 23992279
    [Abstract] [Full Text] [Related]

  • 34. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
    Pereira P, Kapoor A, Sinha A, Agarwal SK, Pande S, Khanna R, Srivastava N, Kumar S, Garg N, Tewari S, Goel P.
    Indian J Med Res; 2017 Dec 26; 146(6):722-729. PubMed ID: 29664030
    [Abstract] [Full Text] [Related]

  • 35. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
    Mathews R, Wang TY, Honeycutt E, Henry TD, Zettler M, Chang M, Fonarow GC, Peterson ED, TRANSLATE-ACS Study Investigators.
    Am Heart J; 2015 Jul 26; 170(1):62-9. PubMed ID: 26093865
    [Abstract] [Full Text] [Related]

  • 36. Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR).
    Zeymer U, Berkenboom G, Coufal Z, Belger M, Sartral M, Norrbacka K, Bakhai A, APTOR investigators.
    Int J Cardiol; 2013 Dec 10; 170(2):239-45. PubMed ID: 24225199
    [Abstract] [Full Text] [Related]

  • 37. Optimizing prevention and guideline-concordant care in Montenegro.
    Knežević B, Musić L, Batrićević G, Bošković A, Bulatović N, Nenezić A, Vujović J, Kalezić M.
    Int J Cardiol; 2016 Aug 10; 217 Suppl():S32-6. PubMed ID: 27381861
    [Abstract] [Full Text] [Related]

  • 38. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U, Kirchberger I, Heier M, Zirngibl A, von Scheidt W, Kuch B, Peters A, Meisinger C.
    Am J Cardiol; 2014 Aug 01; 114(3):329-35. PubMed ID: 24927969
    [Abstract] [Full Text] [Related]

  • 39. Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction.
    Chrischilles EA, Schneider KM, Schroeder MC, Letuchy E, Wallace RB, Robinson JG, Brooks JM.
    J Am Geriatr Soc; 2016 Mar 01; 64(3):526-35. PubMed ID: 26928940
    [Abstract] [Full Text] [Related]

  • 40. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar 01; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.